Phathom Pharmaceuticals (PHAT) Treasury Shares (2019 - 2026)

Phathom Pharmaceuticals (PHAT) has 8 years of Treasury Shares data on file, last reported at $3.0 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 409.09% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 409.09% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, down 9.57% from the prior year.
• Treasury Shares for Q1 2026 stood at $3.0 million, up from $19.0 in the prior quarter.
• Over the last five years, Treasury Shares for PHAT reached as high as $3.0 million in Q1 2026 and fell as low as $19.0 in Q2 2023.
• Historically, Treasury Shares has averaged $714821.2 across 5 years, with a median of $254437.0 in 2022.
• Across the five-year window, Treasury Shares sank 100.0% in 2023 and surged 15313463.16% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $254437.0 in 2022, then tumbled by 99.99% to $19.0 in 2023, then changed by 0.0% to $19.0 in 2024, then changed by 0.0% to $19.0 in 2025, then soared by 15642410.53% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $3.0 million in Q1 2026, $19.0 in Q4 2025, and $667775.0 in Q3 2025.